Close

NextPharma Announces the Addition of a New Encapsulation/Over-encapsulation Machine

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Roche Looks to Expand its Drug Production in the US

Roche is planning to expand its drug production in...

How Language Barriers Impact Non-Native English Speakers in Healthcare

Language barriers create significant challenges for non-native English speakers...

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

NextPharma the leading European provider of product development, contract manufacturing and cold chain and logistics outsourcing services to the pharmaceutical and biotech industry, is pleased to announce that it has enhanced its Clinical Trials Services (CTS)  facility in Göttingen, Germany through the installation of a ModuC LS  IPC encapsulation/over-encapsulation capsule filling machine.

The new machine is  fully automated and capable of  filling and over-encapsulating a wide range of solid and liquid products. At present it has  filling stations for powders, granules, pellets, tablets, capsules and micro tablets. Dependent upon demand, further filling stations  can be added. The filling stations can  be  operated individually or in combination enabling a wide range of filling possibilities. As a result of this flexibility NextPharma can  efficiently and cost-effectively  encapsulate and over-encapsulate

investigational medicinal products with a speed of up to 20,000 units per hour. The machine also has the additional security of having 100% online weight control of each capsule.

Latest stories

Related stories

Roche Looks to Expand its Drug Production in the US

Roche is planning to expand its drug production in...

How Language Barriers Impact Non-Native English Speakers in Healthcare

Language barriers create significant challenges for non-native English speakers...

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back